Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023
|
Subjects: | |
Online Access: | https://repository.londonmet.ac.uk/8982/1/1-s2.0-S2666776223002156-main.pdf |
_version_ | 1804072962383413248 |
---|---|
author | Sadeghimakki, Roham Tahrani, Abd A. |
author_facet | Sadeghimakki, Roham Tahrani, Abd A. |
author_sort | Sadeghimakki, Roham |
collection | LMU |
description | Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome on cardiopulmonary outcomes is clinically important, given the growing global prevalence of metabolic syndrome, driven in part by the increasing obesity rates, and its associations with major adverse cardiovascular events and all-cause mortality. |
first_indexed | 2024-07-09T04:07:29Z |
format | Article |
id | oai:repository.londonmet.ac.uk:8982 |
institution | London Metropolitan University |
language | English |
last_indexed | 2024-07-09T04:07:29Z |
publishDate | 2023 |
publisher | Elsevier |
record_format | eprints |
spelling | oai:repository.londonmet.ac.uk:89822024-01-04T14:43:12Z http://repository.londonmet.ac.uk/8982/ Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome Sadeghimakki, Roham Tahrani, Abd A. 610 Medicine & health Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome on cardiopulmonary outcomes is clinically important, given the growing global prevalence of metabolic syndrome, driven in part by the increasing obesity rates, and its associations with major adverse cardiovascular events and all-cause mortality. Elsevier 2023-12 Article PeerReviewed text en cc_by_nc_nd_4 https://repository.londonmet.ac.uk/8982/1/1-s2.0-S2666776223002156-main.pdf Sadeghimakki, Roham and Tahrani, Abd A. (2023) Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome. The Lancet regional health. Europe, 35 (100796). pp. 1-2. ISSN 2666-7762 https://doi.org/10.1016/j.lanepe.2023.100796 10.1016/j.lanepe.2023.100796 |
spellingShingle | 610 Medicine & health Sadeghimakki, Roham Tahrani, Abd A. Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome |
title | Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome |
title_full | Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome |
title_fullStr | Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome |
title_full_unstemmed | Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome |
title_short | Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome |
title_sort | cardiopulmonary outcomes in people with impaired lung function the role of metabolic syndrome |
topic | 610 Medicine & health |
url | https://repository.londonmet.ac.uk/8982/1/1-s2.0-S2666776223002156-main.pdf |
work_keys_str_mv | AT sadeghimakkiroham cardiopulmonaryoutcomesinpeoplewithimpairedlungfunctiontheroleofmetabolicsyndrome AT tahraniabda cardiopulmonaryoutcomesinpeoplewithimpairedlungfunctiontheroleofmetabolicsyndrome |